🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study examining the safety of AGS-22M6E or ASG-22CE administered as monot...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2011-07-11
Trial ID
NCT01409135
This phase II trial compares therapeutic plasma exchange followed by enfort...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-08-01
Trial ID
NCT07087860
This phase I/Ib trial seeks to find out the best dose, possible benefits an...
Status
Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2021-07-23
Trial ID
NCT04878029
This phase II trial tests how well enfortumab vedotin (EV) and pembrolizuma...
Status
Recruiting
Location
Grady Health System
Start Date
2023-09-26
Trial ID
NCT05756569
This phase Ib/II trial tests the safety, side effects, and best dose of que...
Status
Not Yet Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-12-01
Trial ID
NCT07667335
This phase II trial tests how well enfortumab vedotin works for treating pa...
Status
Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2023-12-21
Trial ID
NCT06104618
Treatments Being Tested
Purpose: to assess efficacy and safety of Dato-DXd + rilvegostomig as adjuv...
Status
Recruiting
Location
Research Site
Start Date
2026-07-16
Trial ID
NCT07720284
Treatments Being Tested
This phase Ib trial evaluates the best dose, potential benefits, and/or sid...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2022-07-07
Trial ID
NCT04963153
This phase II clinical trial tests how well pembrolizumab plus enfortumab v...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-06-24
Trial ID
NCT05775471
Treatments Being Tested
Researchers are looking for new ways to treat people with urothelial cancer...
Status
Recruiting
Location
UCSF Medical Center at Mission Bay ( Site 5044)
Start Date
2026-02-09
Trial ID
NCT07232602
Treatments Being Tested